Sten Eirik W Jacobsen
Overview
Explore the profile of Sten Eirik W Jacobsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
8366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Carrelha J, Mazzi S, Winroth A, Hagemann-Jensen M, Ziegenhain C, Hogstrand K, et al.
Nat Immunol
. 2024 May;
25(6):1007-1019.
PMID: 38816617
Rare multipotent stem cells replenish millions of blood cells per second through a time-consuming process, passing through multiple stages of increasingly lineage-restricted progenitors. Although insults to the blood-forming system highlight...
4.
Tobiasson M, Pandzic T, Illman J, Nilsson L, Westrom S, Ejerblad E, et al.
J Clin Oncol
. 2024 Jan;
42(12):1378-1390.
PMID: 38232336
Purpose: Clinical relapse is the major threat for patients with myelodysplastic syndrome (MDS) undergoing hematopoietic stem-cell transplantation (HSCT). Early detection of measurable residual disease (MRD) would enable preemptive treatment and...
5.
Dimitriou M, Mortera-Blanco T, Tobiasson M, Mazzi S, Lehander M, Hogstrand K, et al.
Blood
. 2023 Dec;
143(11):953-966.
PMID: 38096358
Relapse after complete remission (CR) remains the main cause of mortality after allogeneic stem cell transplantation for hematological malignancies and, therefore, improved biomarkers for early prediction of relapse remains a...
6.
Moura P, Mortera-Blanco T, Hofman I, Todisco G, Kretzschmar W, Bjorklund A, et al.
Cancer Res
. 2023 Nov;
84(2):211-225.
PMID: 37921711
Significance: Ring sideroblast isolation combined with state-of-the-art multiomics identifies survival mechanisms underlying SF3B1-mutant erythropoiesis and establishes an active role for erythroid differentiation and ring sideroblasts themselves in SF3B1-mutant myelodysplastic syndrome...
7.
Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, et al.
Nat Cancer
. 2023 Oct;
4(10):1474-1490.
PMID: 37783807
Acute myeloid leukemia (AML), the most frequent leukemia in adults, is driven by recurrent somatically acquired genetic lesions in a restricted number of genes. Treatment with tyrosine kinase inhibitors has...
8.
Luis T, Barkas N, Carrelha J, Giustacchini A, Mazzi S, Norfo R, et al.
Nat Commun
. 2023 Sep;
14(1):6062.
PMID: 37770432
Hematopoietic stem cells (HSCs) residing in specialized niches in the bone marrow are responsible for the balanced output of multiple short-lived blood cell lineages in steady-state and in response to...
9.
Belander Stralin K, Carrelha J, Winroth A, Ziegenhain C, Hagemann-Jensen M, Kettyle L, et al.
Cell Res
. 2023 Sep;
33(11):883-886.
PMID: 37674010
No abstract available.
10.
Rodriguez-Meira A, Norfo R, Wen S, Chedeville A, Rahman H, OSullivan J, et al.
Nat Genet
. 2023 Sep;
55(9):1531-1541.
PMID: 37666991
Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-mutation-driven clonal evolution and subsequent transformation is a crucial step toward the design of rational therapeutic strategies. Here we carry...